BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 10509467)

  • 1. Risk-based management: current concepts of treating malignant solid tumors of childhood.
    Grosfeld JL
    J Am Coll Surg; 1999 Oct; 189(4):407-25. PubMed ID: 10509467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Systemic therapy in children and adolescents].
    Kremens B
    Urologe A; 2007 Oct; 46(10):1404-6. PubMed ID: 17823786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of pediatric cancers: problems in the development of a national system.
    Fleming ID
    Semin Surg Oncol; 1992; 8(2):94-7. PubMed ID: 1319608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 23-year experience with malignant renal tumors in infancy and childhood.
    Tröbs RB; Hänsel M; Friedrich T; Bennek J
    Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.
    Reinhard H; Semler O; Bürger D; Bode U; Flentje M; Göbel U; Gutjahr P; Leuschner I; Maass E; Niggli F; Scheel-Walter HG; Stöckle M; Thüroff JW; Tröger J; Weirich A; von Schweinitz D; Zoubek A; Graf N
    Klin Padiatr; 2004; 216(3):132-40. PubMed ID: 15175957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric genitourinary tumors.
    Castellino SM; McLean TW
    Curr Opin Oncol; 2007 May; 19(3):248-53. PubMed ID: 17414644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
    Fernandez CV; Mullen EA; Chi YY; Ehrlich PF; Perlman EJ; Kalapurakal JA; Khanna G; Paulino AC; Hamilton TE; Gow KW; Tochner Z; Hoffer FA; Withycombe JS; Shamberger RC; Kim Y; Geller JI; Anderson JR; Grundy PE; Dome JS
    J Clin Oncol; 2018 Jan; 36(3):254-261. PubMed ID: 29211618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant tumors in infancy and childhood].
    Daum R
    Chirurg; 1996 Jun; 67(6):584-92. PubMed ID: 8767086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcome of Wilms tumors with a favorable histology in Japan: a report from the Study Group for Pediatric Solid Malignant Tumors in the Kyushu Area, Japan.
    Suita S; Kinoshita Y; Tajiri T; Hara T; Tsuneyoshi M; Mizote H; Inada H; Takamatsu H; Kawano Y; Inomata Y; Nagasaki A; Ono Y; Handa N; Okamura J; Ishii E; Kawakami K;
    J Pediatr Surg; 2006 Sep; 41(9):1501-5. PubMed ID: 16952581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of second-look procedures in the management of retroperitoneal tumors in children.
    Grosfeld JL; West KW; Weber TR
    Am J Pediatr Hematol Oncol; 1984; 6(4):441-7. PubMed ID: 6099986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
    Aronson DC; Hadley GP
    Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment results among adults with childhood tumors: a 20-year experience.
    Prestidge BR; Donaldson SS
    Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):507-14. PubMed ID: 2550396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y; Suminoe A; Inada H; Yagi M; Yanai F; Zaizen Y; Nishi M; Inomata Y; Kawakami K; Matsufuji H; Suenobu S; Handa N; Kohashi K; Oda Y; Hara T; Taguchi T
    J Pediatr Surg; 2012 Dec; 47(12):2205-9. PubMed ID: 23217877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome and Biological Predictors of Relapse After Nephrectomy Only for Very Low-risk Wilms Tumor: A Report From Children's Oncology Group AREN0532.
    Fernandez CV; Perlman EJ; Mullen EA; Chi YY; Hamilton TE; Gow KW; Ferrer FA; Barnhart DC; Ehrlich PF; Khanna G; Kalapurakal JA; Bocking T; Huff V; Tian J; Geller JI; Grundy PE; Anderson JR; Dome JS; Shamberger RC
    Ann Surg; 2017 Apr; 265(4):835-840. PubMed ID: 27811504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wilms' tumor: reached progress and future prospects].
    Tamaro P
    Arch Ital Urol Androl; 1997 Sep; 69(4):227-32. PubMed ID: 9417294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of tumor histology on treatment and prognosis of pediatric neoplasms.
    Beckwith JB
    Semin Pediatr Surg; 1993 Feb; 2(1):11-8. PubMed ID: 8062017
    [No Abstract]   [Full Text] [Related]  

  • 18. A single-institution Wilms' tumor and localized neuroblastoma series.
    Boglino C; Inserra A; Madafferi S; Jenkner A; Diomedi Camassei F; Boldrini R; Donfrancesco A
    Acta Paediatr Suppl; 2004 May; 93(445):74-7. PubMed ID: 15176726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative staging, prognostic factors, and outcome for extremity rhabdomyosarcoma: a preliminary report from the Intergroup Rhabdomyosarcoma Study IV (1991-1997).
    Neville HL; Andrassy RJ; Lobe TE; Bagwell CE; Anderson JR; Womer RB; Crist WM; Wiener ES
    J Pediatr Surg; 2000 Feb; 35(2):317-21. PubMed ID: 10693687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.